durvalumab,paclitaxel,carboplatin,cisplatin,gemcitabine,pemetrexed
astrazeneca
[]
dr. john heymach just presented his phase iii results at #aacr23: there is a 32% lower chance of disease recurrence, progression or death with immunotherapy plus chemotherapy versus chemotherapy alone. learn more: 
MD Anderson is a global leader in cancer care, research, education and training, and prevention. Appointments available: 1-877-632-6789